HEADER LIGASE 13-SEP-23 8QJS TITLE VHL/ELONGIN B/ELONGIN C COMPLEX WITH COMPOUND 155 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ELONGIN-B; COMPND 3 CHAIN: A, D, G, J; COMPND 4 SYNONYM: ELOB,ELONGIN 18 KDA SUBUNIT,RNA POLYMERASE II TRANSCRIPTION COMPND 5 FACTOR SIII SUBUNIT B,SIII P18,TRANSCRIPTION ELONGATION FACTOR B COMPND 6 POLYPEPTIDE 2; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ELONGIN-C; COMPND 10 CHAIN: B, E, H, K; COMPND 11 SYNONYM: ELOC,ELONGIN 15 KDA SUBUNIT,RNA POLYMERASE II TRANSCRIPTION COMPND 12 FACTOR SIII SUBUNIT C,SIII P15,TRANSCRIPTION ELONGATION FACTOR B COMPND 13 POLYPEPTIDE 1; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR; COMPND 17 CHAIN: C, F, I, L; COMPND 18 SYNONYM: PROTEIN G7,PVHL; COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ELOB, TCEB2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: ELOC, TCEB1; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: VHL; SOURCE 20 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS VHL, ELONGIN, VBC, E3 LIGASE, VON HIPPEL-LINDAU, UBIQUITINASE, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR P.S.KERRY,A.J.HOLE,J.I.PEREZ-DORADO REVDAT 2 07-FEB-24 8QJS 1 JRNL REVDAT 1 17-JAN-24 8QJS 0 JRNL AUTH M.BERLIN,J.CANTLEY,M.BOOKBINDER,E.BORTOLON,F.BROCCATELLI, JRNL AUTH 2 G.CADELINA,E.W.CHAN,H.CHEN,X.CHEN,Y.CHENG,T.K.CHEUNG, JRNL AUTH 3 K.DAVENPORT,D.DINICOLA,D.GORDON,B.D.HAMMAN,A.HARBIN, JRNL AUTH 4 R.HASKELL,M.HE,A.J.HOLE,T.JANUARIO,P.S.KERRY,S.G.KOENIG, JRNL AUTH 5 L.LI,M.MERCHANT,I.PEREZ-DORADO,J.PIZZANO,C.QUINN,C.M.ROSE, JRNL AUTH 6 E.ROUSSEAU,L.SOTO,L.R.STABEN,H.SUN,Q.TIAN,J.WANG,W.WANG, JRNL AUTH 7 C.S.YE,X.YE,P.ZHANG,Y.ZHOU,R.YAUCH,P.S.DRAGOVICH JRNL TITL PROTACS TARGETING BRM (SMARCA2) AFFORD SELECTIVE IN VIVO JRNL TITL 2 DEGRADATION OVER BRG1 (SMARCA4) AND ARE ACTIVE IN BRG1 JRNL TITL 3 MUTANT XENOGRAFT TUMOR MODELS. JRNL REF J.MED.CHEM. V. 67 1262 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38180485 JRNL DOI 10.1021/ACS.JMEDCHEM.3C01781 REMARK 2 REMARK 2 RESOLUTION. 3.19 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 (8-JUN-2022) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.19 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 27350 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.255 REMARK 3 R VALUE (WORKING SET) : 0.254 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1397 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.19 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.21 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.18 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3382 REMARK 3 BIN FREE R VALUE : 0.2927 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 18 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 10846 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 168 REMARK 3 SOLVENT ATOMS : 15 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 73.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.86500 REMARK 3 B22 (A**2) : -5.86500 REMARK 3 B33 (A**2) : 11.73000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.500 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.552 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.920 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.907 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 11269 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 15296 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 3958 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 1881 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 11269 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1463 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 8300 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 0.87 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.97 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.37 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8QJS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1292133088. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JAN-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9121 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27684 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.018 REMARK 200 RESOLUTION RANGE LOW (A) : 48.760 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.00 REMARK 200 R MERGE (I) : 0.16000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.02 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.25 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.86100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM SODIUM CITRATE PH 6.0, 200 MM REMARK 280 MAGNESIUM ACETATE, 50 MM DTT, 14% PEG 8000, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z+1/2 REMARK 290 7555 Y,X,-Z+3/4 REMARK 290 8555 -Y,-X,-Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 180.95200 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 90.47600 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 271.42800 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 180.95200 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 271.42800 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 90.47600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4690 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -38.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, H, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: J, K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 104 REMARK 465 GLY B 48 REMARK 465 PRO B 49 REMARK 465 GLY B 50 REMARK 465 GLN B 51 REMARK 465 PHE B 52 REMARK 465 ALA B 53 REMARK 465 GLU B 54 REMARK 465 ASN B 55 REMARK 465 GLU B 56 REMARK 465 GLY C 52 REMARK 465 SER C 53 REMARK 465 MET C 54 REMARK 465 GLU C 55 REMARK 465 ALA C 56 REMARK 465 GLY C 57 REMARK 465 ARG C 58 REMARK 465 PRO C 59 REMARK 465 ARG C 60 REMARK 465 GLN C 209 REMARK 465 ARG C 210 REMARK 465 MET C 211 REMARK 465 GLY C 212 REMARK 465 ASP C 213 REMARK 465 ARG D 80 REMARK 465 ALA D 81 REMARK 465 ASP D 82 REMARK 465 LYS D 104 REMARK 465 MET E 16 REMARK 465 PRO E 49 REMARK 465 GLY E 50 REMARK 465 GLN E 51 REMARK 465 PHE E 52 REMARK 465 ALA E 53 REMARK 465 GLU E 54 REMARK 465 ASN E 55 REMARK 465 GLU E 56 REMARK 465 GLY F 52 REMARK 465 SER F 53 REMARK 465 MET F 54 REMARK 465 GLU F 55 REMARK 465 ALA F 56 REMARK 465 GLY F 57 REMARK 465 ARG F 58 REMARK 465 PRO F 59 REMARK 465 ARG F 60 REMARK 465 ALA F 207 REMARK 465 HIS F 208 REMARK 465 GLN F 209 REMARK 465 ARG F 210 REMARK 465 MET F 211 REMARK 465 GLY F 212 REMARK 465 ASP F 213 REMARK 465 LYS G 104 REMARK 465 GLY H 48 REMARK 465 PRO H 49 REMARK 465 GLY H 50 REMARK 465 GLN H 51 REMARK 465 PHE H 52 REMARK 465 ALA H 53 REMARK 465 GLU H 54 REMARK 465 ASN H 55 REMARK 465 GLU H 56 REMARK 465 GLY I 52 REMARK 465 SER I 53 REMARK 465 MET I 54 REMARK 465 GLU I 55 REMARK 465 ALA I 56 REMARK 465 GLY I 57 REMARK 465 ARG I 58 REMARK 465 PRO I 59 REMARK 465 ARG I 60 REMARK 465 PRO I 61 REMARK 465 ARG I 210 REMARK 465 MET I 211 REMARK 465 GLY I 212 REMARK 465 ASP I 213 REMARK 465 LYS J 104 REMARK 465 MET K 16 REMARK 465 PRO K 49 REMARK 465 GLY K 50 REMARK 465 GLN K 51 REMARK 465 PHE K 52 REMARK 465 ALA K 53 REMARK 465 GLU K 54 REMARK 465 ASN K 55 REMARK 465 GLU K 56 REMARK 465 GLY L 52 REMARK 465 SER L 53 REMARK 465 MET L 54 REMARK 465 GLU L 55 REMARK 465 ALA L 56 REMARK 465 GLY L 57 REMARK 465 ARG L 58 REMARK 465 PRO L 59 REMARK 465 ARG L 60 REMARK 465 PRO L 61 REMARK 465 HIS L 208 REMARK 465 GLN L 209 REMARK 465 ARG L 210 REMARK 465 MET L 211 REMARK 465 GLY L 212 REMARK 465 ASP L 213 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 10 -111.68 56.27 REMARK 500 ASP A 47 -125.69 65.80 REMARK 500 ASP A 83 -12.79 70.58 REMARK 500 ARG C 79 46.83 -93.55 REMARK 500 ASN C 90 -178.55 -64.52 REMARK 500 HIS D 10 -113.22 55.33 REMARK 500 ASP D 47 -124.75 65.25 REMARK 500 ARG F 69 43.42 -88.33 REMARK 500 ARG F 79 44.25 -87.91 REMARK 500 ASN F 90 -179.60 -67.83 REMARK 500 HIS G 10 -113.31 55.47 REMARK 500 ASP G 47 -125.25 65.24 REMARK 500 ASP G 83 -12.10 69.78 REMARK 500 ARG I 79 45.88 -99.18 REMARK 500 ASN I 90 -179.17 -67.62 REMARK 500 HIS J 10 -113.48 55.52 REMARK 500 ASP J 47 -124.43 64.51 REMARK 500 ALA J 67 71.64 -119.29 REMARK 500 ALA J 71 71.96 -150.36 REMARK 500 ASP J 83 -12.94 70.74 REMARK 500 ASN K 58 -51.57 67.25 REMARK 500 ARG L 79 46.69 -93.13 REMARK 500 ASN L 90 -179.28 -68.08 REMARK 500 SER L 111 -161.23 -129.27 REMARK 500 REMARK 500 REMARK: NULL DBREF 8QJS A 1 104 UNP Q15370 ELOB_HUMAN 1 104 DBREF 8QJS B 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 8QJS C 54 213 UNP P40337 VHL_HUMAN 54 213 DBREF 8QJS D 1 104 UNP Q15370 ELOB_HUMAN 1 104 DBREF 8QJS E 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 8QJS F 54 213 UNP P40337 VHL_HUMAN 54 213 DBREF 8QJS G 1 104 UNP Q15370 ELOB_HUMAN 1 104 DBREF 8QJS H 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 8QJS I 54 213 UNP P40337 VHL_HUMAN 54 213 DBREF 8QJS J 1 104 UNP Q15370 ELOB_HUMAN 1 104 DBREF 8QJS K 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 8QJS L 54 213 UNP P40337 VHL_HUMAN 54 213 SEQADV 8QJS MET B 16 UNP Q15369 INITIATING METHIONINE SEQADV 8QJS GLY C 52 UNP P40337 EXPRESSION TAG SEQADV 8QJS SER C 53 UNP P40337 EXPRESSION TAG SEQADV 8QJS MET E 16 UNP Q15369 INITIATING METHIONINE SEQADV 8QJS GLY F 52 UNP P40337 EXPRESSION TAG SEQADV 8QJS SER F 53 UNP P40337 EXPRESSION TAG SEQADV 8QJS MET H 16 UNP Q15369 INITIATING METHIONINE SEQADV 8QJS GLY I 52 UNP P40337 EXPRESSION TAG SEQADV 8QJS SER I 53 UNP P40337 EXPRESSION TAG SEQADV 8QJS MET K 16 UNP Q15369 INITIATING METHIONINE SEQADV 8QJS GLY L 52 UNP P40337 EXPRESSION TAG SEQADV 8QJS SER L 53 UNP P40337 EXPRESSION TAG SEQRES 1 A 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 A 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 A 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 A 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 A 104 ASP GLY LYS THR LEU GLY GLU CYS GLY PHE THR SER GLN SEQRES 6 A 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 A 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CYS ILE GLU SEQRES 8 A 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 1 B 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 B 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 B 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 B 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 B 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 B 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 B 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 B 97 ALA ASN PHE LEU ASP CYS SEQRES 1 C 162 GLY SER MET GLU ALA GLY ARG PRO ARG PRO VAL LEU ARG SEQRES 2 C 162 SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE CYS SEQRES 3 C 162 ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU ASN SEQRES 4 C 162 PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO PRO SEQRES 5 C 162 GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS LEU SEQRES 6 C 162 TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU LEU SEQRES 7 C 162 VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN VAL SEQRES 8 C 162 ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO VAL SEQRES 9 C 162 TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SER SEQRES 10 C 162 LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE VAL SEQRES 11 C 162 ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN VAL SEQRES 12 C 162 GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE ALA SEQRES 13 C 162 HIS GLN ARG MET GLY ASP SEQRES 1 D 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 D 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 D 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 D 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 D 104 ASP GLY LYS THR LEU GLY GLU CYS GLY PHE THR SER GLN SEQRES 6 D 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 D 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CYS ILE GLU SEQRES 8 D 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 1 E 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 E 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 E 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 E 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 E 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 E 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 E 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 E 97 ALA ASN PHE LEU ASP CYS SEQRES 1 F 162 GLY SER MET GLU ALA GLY ARG PRO ARG PRO VAL LEU ARG SEQRES 2 F 162 SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE CYS SEQRES 3 F 162 ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU ASN SEQRES 4 F 162 PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO PRO SEQRES 5 F 162 GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS LEU SEQRES 6 F 162 TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU LEU SEQRES 7 F 162 VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN VAL SEQRES 8 F 162 ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO VAL SEQRES 9 F 162 TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SER SEQRES 10 F 162 LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE VAL SEQRES 11 F 162 ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN VAL SEQRES 12 F 162 GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE ALA SEQRES 13 F 162 HIS GLN ARG MET GLY ASP SEQRES 1 G 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 G 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 G 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 G 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 G 104 ASP GLY LYS THR LEU GLY GLU CYS GLY PHE THR SER GLN SEQRES 6 G 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 G 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CYS ILE GLU SEQRES 8 G 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 1 H 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 H 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 H 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 H 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 H 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 H 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 H 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 H 97 ALA ASN PHE LEU ASP CYS SEQRES 1 I 162 GLY SER MET GLU ALA GLY ARG PRO ARG PRO VAL LEU ARG SEQRES 2 I 162 SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE CYS SEQRES 3 I 162 ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU ASN SEQRES 4 I 162 PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO PRO SEQRES 5 I 162 GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS LEU SEQRES 6 I 162 TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU LEU SEQRES 7 I 162 VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN VAL SEQRES 8 I 162 ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO VAL SEQRES 9 I 162 TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SER SEQRES 10 I 162 LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE VAL SEQRES 11 I 162 ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN VAL SEQRES 12 I 162 GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE ALA SEQRES 13 I 162 HIS GLN ARG MET GLY ASP SEQRES 1 J 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 J 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 J 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 J 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 J 104 ASP GLY LYS THR LEU GLY GLU CYS GLY PHE THR SER GLN SEQRES 6 J 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 J 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CYS ILE GLU SEQRES 8 J 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 1 K 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 K 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 K 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 K 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 K 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 K 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 K 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 K 97 ALA ASN PHE LEU ASP CYS SEQRES 1 L 162 GLY SER MET GLU ALA GLY ARG PRO ARG PRO VAL LEU ARG SEQRES 2 L 162 SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE CYS SEQRES 3 L 162 ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU ASN SEQRES 4 L 162 PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO PRO SEQRES 5 L 162 GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS LEU SEQRES 6 L 162 TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU LEU SEQRES 7 L 162 VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN VAL SEQRES 8 L 162 ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO VAL SEQRES 9 L 162 TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SER SEQRES 10 L 162 LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE VAL SEQRES 11 L 162 ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN VAL SEQRES 12 L 162 GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE ALA SEQRES 13 L 162 HIS GLN ARG MET GLY ASP HET VL6 C 301 42 HET VL6 F 301 42 HET VL6 I 301 42 HET VL6 L 301 42 HETNAM VL6 (2S,4R)-1-[(2R)-2-[3-[2-(2-METHOXYETHOXY)ETHOXY]-1,2- HETNAM 2 VL6 OXAZOL-5-YL]-3-METHYL-BUTANOYL]-N-[(1S)-1-[4-(4- HETNAM 3 VL6 METHYL-1,3-THIAZOL-5-YL)PHENYL]ETHYL]-4-OXIDANYL- HETNAM 4 VL6 PYRROLIDINE-2-CARBOXAMIDE FORMUL 13 VL6 4(C30 H40 N4 O7 S) FORMUL 17 HOH *15(H2 O) HELIX 1 AA1 THR A 23 LYS A 36 1 14 HELIX 2 AA2 PRO A 38 ASP A 40 5 3 HELIX 3 AA3 ARG B 33 LEU B 37 1 5 HELIX 4 AA4 SER B 39 SER B 47 1 9 HELIX 5 AA5 PRO B 66 THR B 84 1 19 HELIX 6 AA6 ALA B 96 ASP B 111 1 16 HELIX 7 AA7 ASN C 141 GLN C 145 5 5 HELIX 8 AA8 THR C 157 VAL C 170 1 14 HELIX 9 AA9 LYS C 171 LEU C 178 5 8 HELIX 10 AB1 VAL C 181 ASP C 190 1 10 HELIX 11 AB2 ASN C 193 HIS C 208 1 16 HELIX 12 AB3 THR D 23 LYS D 36 1 14 HELIX 13 AB4 PRO D 38 GLN D 42 5 5 HELIX 14 AB5 ARG E 33 LEU E 37 1 5 HELIX 15 AB6 SER E 39 SER E 47 1 9 HELIX 16 AB7 PRO E 66 THR E 84 1 19 HELIX 17 AB8 ALA E 96 ASP E 111 1 16 HELIX 18 AB9 ASN F 141 GLN F 145 5 5 HELIX 19 AC1 THR F 157 VAL F 170 1 14 HELIX 20 AC2 LYS F 171 TYR F 175 5 5 HELIX 21 AC3 VAL F 181 ASP F 190 1 10 HELIX 22 AC4 ASN F 193 ILE F 206 1 14 HELIX 23 AC5 THR G 23 LYS G 36 1 14 HELIX 24 AC6 PRO G 38 ASP G 40 5 3 HELIX 25 AC7 ARG H 33 LEU H 37 1 5 HELIX 26 AC8 SER H 39 SER H 47 1 9 HELIX 27 AC9 PRO H 66 THR H 84 1 19 HELIX 28 AD1 ALA H 96 ASP H 111 1 16 HELIX 29 AD2 THR I 157 VAL I 170 1 14 HELIX 30 AD3 LYS I 171 LEU I 178 5 8 HELIX 31 AD4 VAL I 181 ASP I 190 1 10 HELIX 32 AD5 ASN I 193 HIS I 208 1 16 HELIX 33 AD6 THR J 23 LYS J 36 1 14 HELIX 34 AD7 PRO J 38 ASP J 40 5 3 HELIX 35 AD8 ARG K 33 LEU K 37 1 5 HELIX 36 AD9 SER K 39 SER K 47 1 9 HELIX 37 AE1 PRO K 66 THR K 84 1 19 HELIX 38 AE2 ILE K 99 ASP K 111 1 13 HELIX 39 AE3 ASN L 141 GLN L 145 5 5 HELIX 40 AE4 THR L 157 VAL L 170 1 14 HELIX 41 AE5 LYS L 171 LEU L 178 5 8 HELIX 42 AE6 VAL L 181 ASP L 190 1 10 HELIX 43 AE7 ASN L 193 ALA L 207 1 15 SHEET 1 AA1 4 GLN A 49 LEU A 50 0 SHEET 2 AA1 4 GLN A 42 LYS A 46 -1 N LYS A 46 O GLN A 49 SHEET 3 AA1 4 ALA A 73 ALA A 81 -1 O GLY A 76 N TYR A 45 SHEET 4 AA1 4 THR A 84 PHE A 85 -1 O THR A 84 N ALA A 81 SHEET 1 AA2 8 GLN A 49 LEU A 50 0 SHEET 2 AA2 8 GLN A 42 LYS A 46 -1 N LYS A 46 O GLN A 49 SHEET 3 AA2 8 ALA A 73 ALA A 81 -1 O GLY A 76 N TYR A 45 SHEET 4 AA2 8 ASP A 2 ARG A 9 1 N ARG A 8 O VAL A 75 SHEET 5 AA2 8 THR A 12 LYS A 19 -1 O THR A 16 N LEU A 5 SHEET 6 AA2 8 GLU B 28 LYS B 32 1 O ILE B 30 N PHE A 15 SHEET 7 AA2 8 TYR B 18 ILE B 22 -1 N LEU B 21 O PHE B 29 SHEET 8 AA2 8 GLU B 59 ASN B 61 1 O VAL B 60 N ILE B 22 SHEET 1 AA3 4 GLY C 106 TYR C 112 0 SHEET 2 AA3 4 PRO C 71 ASN C 78 -1 N VAL C 74 O ILE C 109 SHEET 3 AA3 4 ILE C 147 THR C 152 1 O ALA C 149 N ILE C 75 SHEET 4 AA3 4 LEU C 129 VAL C 130 -1 N LEU C 129 O THR C 152 SHEET 1 AA4 3 PRO C 95 PRO C 97 0 SHEET 2 AA4 3 VAL C 84 LEU C 89 -1 N TRP C 88 O GLN C 96 SHEET 3 AA4 3 LEU C 116 ASP C 121 -1 O ARG C 120 N LEU C 85 SHEET 1 AA5 8 GLN D 49 LEU D 50 0 SHEET 2 AA5 8 ARG D 43 LYS D 46 -1 N LYS D 46 O GLN D 49 SHEET 3 AA5 8 ALA D 73 ALA D 78 -1 O GLY D 76 N TYR D 45 SHEET 4 AA5 8 ASP D 2 ARG D 9 1 N ARG D 8 O VAL D 75 SHEET 5 AA5 8 THR D 12 LYS D 19 -1 O THR D 16 N LEU D 5 SHEET 6 AA5 8 GLU E 28 LYS E 32 1 O ILE E 30 N THR D 13 SHEET 7 AA5 8 TYR E 18 ILE E 22 -1 N VAL E 19 O VAL E 31 SHEET 8 AA5 8 GLU E 59 ASN E 61 1 O VAL E 60 N ILE E 22 SHEET 1 AA6 4 GLY F 106 TYR F 112 0 SHEET 2 AA6 4 PRO F 71 ASN F 78 -1 N VAL F 74 O ILE F 109 SHEET 3 AA6 4 ILE F 147 THR F 152 1 O ALA F 149 N ILE F 75 SHEET 4 AA6 4 LEU F 129 VAL F 130 -1 N LEU F 129 O THR F 152 SHEET 1 AA7 3 PRO F 95 PRO F 97 0 SHEET 2 AA7 3 VAL F 84 LEU F 89 -1 N TRP F 88 O GLN F 96 SHEET 3 AA7 3 LEU F 116 ASP F 121 -1 O ARG F 120 N LEU F 85 SHEET 1 AA8 4 GLN G 49 LEU G 50 0 SHEET 2 AA8 4 GLN G 42 LYS G 46 -1 N LYS G 46 O GLN G 49 SHEET 3 AA8 4 ALA G 73 ALA G 81 -1 O GLY G 76 N TYR G 45 SHEET 4 AA8 4 THR G 84 PHE G 85 -1 O THR G 84 N ALA G 81 SHEET 1 AA9 8 GLN G 49 LEU G 50 0 SHEET 2 AA9 8 GLN G 42 LYS G 46 -1 N LYS G 46 O GLN G 49 SHEET 3 AA9 8 ALA G 73 ALA G 81 -1 O GLY G 76 N TYR G 45 SHEET 4 AA9 8 ASP G 2 ARG G 9 1 N ARG G 8 O VAL G 75 SHEET 5 AA9 8 THR G 12 LYS G 19 -1 O ALA G 18 N VAL G 3 SHEET 6 AA9 8 GLU H 28 LYS H 32 1 O ILE H 30 N PHE G 15 SHEET 7 AA9 8 TYR H 18 ILE H 22 -1 N LEU H 21 O PHE H 29 SHEET 8 AA9 8 GLU H 59 ASN H 61 1 O VAL H 60 N ILE H 22 SHEET 1 AB1 4 GLY I 106 TYR I 112 0 SHEET 2 AB1 4 PRO I 71 ASN I 78 -1 N VAL I 74 O ILE I 109 SHEET 3 AB1 4 ILE I 147 THR I 152 1 O ILE I 151 N CYS I 77 SHEET 4 AB1 4 LEU I 129 VAL I 130 -1 N LEU I 129 O THR I 152 SHEET 1 AB2 3 PRO I 95 PRO I 97 0 SHEET 2 AB2 3 VAL I 84 LEU I 89 -1 N TRP I 88 O GLN I 96 SHEET 3 AB2 3 LEU I 116 ASP I 121 -1 O ARG I 120 N LEU I 85 SHEET 1 AB3 4 GLN J 49 LEU J 50 0 SHEET 2 AB3 4 GLN J 42 LYS J 46 -1 N LYS J 46 O GLN J 49 SHEET 3 AB3 4 ALA J 73 ALA J 81 -1 O GLY J 76 N TYR J 45 SHEET 4 AB3 4 THR J 84 PHE J 85 -1 O THR J 84 N ALA J 81 SHEET 1 AB4 8 GLN J 49 LEU J 50 0 SHEET 2 AB4 8 GLN J 42 LYS J 46 -1 N LYS J 46 O GLN J 49 SHEET 3 AB4 8 ALA J 73 ALA J 81 -1 O GLY J 76 N TYR J 45 SHEET 4 AB4 8 ASP J 2 ARG J 9 1 N ARG J 8 O VAL J 75 SHEET 5 AB4 8 THR J 12 LYS J 19 -1 O THR J 16 N LEU J 5 SHEET 6 AB4 8 GLU K 28 LYS K 32 1 O ILE K 30 N PHE J 15 SHEET 7 AB4 8 TYR K 18 ILE K 22 -1 N LEU K 21 O PHE K 29 SHEET 8 AB4 8 GLU K 59 ASN K 61 1 O VAL K 60 N ILE K 22 SHEET 1 AB5 4 GLY L 106 TYR L 112 0 SHEET 2 AB5 4 PRO L 71 ASN L 78 -1 N VAL L 74 O ILE L 109 SHEET 3 AB5 4 ILE L 147 THR L 152 1 O ALA L 149 N ILE L 75 SHEET 4 AB5 4 LEU L 129 VAL L 130 -1 N LEU L 129 O THR L 152 SHEET 1 AB6 3 PRO L 95 PRO L 97 0 SHEET 2 AB6 3 VAL L 84 LEU L 89 -1 N TRP L 88 O GLN L 96 SHEET 3 AB6 3 LEU L 116 ASP L 121 -1 O ARG L 120 N LEU L 85 CRYST1 93.235 93.235 361.904 90.00 90.00 90.00 P 41 2 2 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010726 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010726 0.000000 0.00000 SCALE3 0.000000 0.000000 0.002763 0.00000